Candorium Free Members
Join Candorium to access the full article and more
Free Member Benefits:
✔
Comment & Reply✔
Newsletter Access✔
Follow Authors✔
Share via SMS Go Back
Coherus BioSciences: Q4 Earnings Snapshot
By AP News - Mar 10, 2025, 04:50 PM ET
Last Updated - Mar 10, 2025, 04:50 PM EDT
REDWOOD CITY, Calif. (AP) — REDWOOD CITY, Calif. (AP) — Coherus BioSciences Inc. (CHRS) on Monday reported a loss of $50.7 million in its fourth quarter.
The Redwood City, California-based company said it had a loss of 44 cents per share. Losses, adjusted for non-recurring costs and stock option expense, came to 28 cents per share.
Sponsored
The drug developer posted revenue of $54.1 million in the period.
For the year, the company reported profit of $28.5 million, or 25 cents per share. Revenue was reported as $267 million.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on CHRS at https://www.zacks.com/ap/CHRS
Sponsored
Read More from Investing
Popular News
Latest News